Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research

Detalhes bibliográficos
Autor(a) principal: Coelho, André
Data de Publicação: 2020
Outros Autores: Alvites, Rui Damásio, Branquinho, Mariana Vieira, Guerreiro, Susana G., Maurício, Ana Colette
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.22/16649
Resumo: In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines and specific treatments are not yet available. There are several strategies currently being studied for the treatment of adverse symptoms of COVID-19, that encompass Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS), extensive pulmonary inflammation, cytokine storm, and pulmonary edema, due to virus-induced pneumonia.
id RCAP_f2c5fcb94ce0ebcea5ee194f108a0f1e
oai_identifier_str oai:recipp.ipp.pt:10400.22/16649
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature ResearchCell-based therapiesSecretomeMesenchymal stem cellsCoronavirusSARS-CoV-2In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines and specific treatments are not yet available. There are several strategies currently being studied for the treatment of adverse symptoms of COVID-19, that encompass Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS), extensive pulmonary inflammation, cytokine storm, and pulmonary edema, due to virus-induced pneumonia.Frontiers in Cell and Developmental BiologyRepositório Científico do Instituto Politécnico do PortoCoelho, AndréAlvites, Rui DamásioBranquinho, Mariana VieiraGuerreiro, Susana G.Maurício, Ana Colette2021-01-05T11:37:07Z2020-11-192020-11-19T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.22/16649engCoelho, A., Alvites, R. D., Branquinho, M. V., Guerreiro, S. G., & Maurício, A. C. (2020). Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research. Frontiers in Cell and Developmental Biology, 8, 602647. https://doi.org/10.3389/fcell.2020.60264710.3389/fcell.2020.602647info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-13T01:49:53Zoai:recipp.ipp.pt:10400.22/16649Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:36:17.450646Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research
title Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research
spellingShingle Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research
Coelho, André
Cell-based therapies
Secretome
Mesenchymal stem cells
Coronavirus
SARS-CoV-2
title_short Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research
title_full Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research
title_fullStr Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research
title_full_unstemmed Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research
title_sort Mesenchymal Stem Cells (MSCs) as a potential therapeutic Strategy in COVID-19 Patients: Literature Research
author Coelho, André
author_facet Coelho, André
Alvites, Rui Damásio
Branquinho, Mariana Vieira
Guerreiro, Susana G.
Maurício, Ana Colette
author_role author
author2 Alvites, Rui Damásio
Branquinho, Mariana Vieira
Guerreiro, Susana G.
Maurício, Ana Colette
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Politécnico do Porto
dc.contributor.author.fl_str_mv Coelho, André
Alvites, Rui Damásio
Branquinho, Mariana Vieira
Guerreiro, Susana G.
Maurício, Ana Colette
dc.subject.por.fl_str_mv Cell-based therapies
Secretome
Mesenchymal stem cells
Coronavirus
SARS-CoV-2
topic Cell-based therapies
Secretome
Mesenchymal stem cells
Coronavirus
SARS-CoV-2
description In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines and specific treatments are not yet available. There are several strategies currently being studied for the treatment of adverse symptoms of COVID-19, that encompass Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS), extensive pulmonary inflammation, cytokine storm, and pulmonary edema, due to virus-induced pneumonia.
publishDate 2020
dc.date.none.fl_str_mv 2020-11-19
2020-11-19T00:00:00Z
2021-01-05T11:37:07Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.22/16649
url http://hdl.handle.net/10400.22/16649
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Coelho, A., Alvites, R. D., Branquinho, M. V., Guerreiro, S. G., & Maurício, A. C. (2020). Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research. Frontiers in Cell and Developmental Biology, 8, 602647. https://doi.org/10.3389/fcell.2020.602647
10.3389/fcell.2020.602647
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers in Cell and Developmental Biology
publisher.none.fl_str_mv Frontiers in Cell and Developmental Biology
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131453828628480

Registros relacionados